Did Anthropic Suck the Air From Palantir’s Commercial Contract Tailwinds?

Photo of Rich Duprey
By Rich Duprey Published

Quick Read

  • Palantir (PLTR) posted Q1 2025 U.S. commercial revenue of $507M up 137% YoY with guidance for at least 115% U.S. commercial growth in 2026.

  • Anthropic’s enterprise Claude rollout is pressuring Palantir’s software sales as the market reshuffles AI vendor selection.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Did Anthropic Suck the Air From Palantir’s Commercial Contract Tailwinds?

© Anthropic

Palantir Technologies (NASDAQ: PLTR | PLTR Price Prediction) reports Q1 2026 results after the close today. Management guided at least 115% U.S. commercial growth for the year just as Anthropic’s enterprise AI push reshaped software buying. I’ll be watching whether commercial momentum held.

Commercial Acceleration Meets a New Competitor

Last quarter Palantir delivered $1.41B in revenue, up 70% YoY, with U.S. commercial revenue of $507 million, up 137% year-over-year and 28% sequentially. Total contract value closed reached $4.262B, up 138%, and CEO Alex Karp called the firm “an n of 1” with a Rule of 40 score of 127.

Then came what investors dubbed the “SaaS-pocalypse”, as Anthropic’s enterprise Claude rollouts earlier this year forced buyers to rethink software stacks. Shares are down 18.95% year-to-date into today’s report, even after a 23.98% one-year gain. The question is whether commercial demand kept compounding through that competitive shock.

Consensus and Guidance Snapshot

Metric Q1 2026 Guide YoY Comparison
Revenue $1.532B-$1.536B ~73% YoY vs Q1 2025 $883.86M
Adj. Operating Income $870M-$874M n/a
FY 2026 Revenue $7.182B-$7.198B ~61% YoY vs $4.475B FY 2025
FY 2026 U.S. Commercial >$3.144B at least 115% YoY
FY 2025 Reported EPS $0.75 n/a

Commercial Velocity vs. Anthropic Pressure

Watch the U.S. commercial line above all. The 2025 ramp tells the story: $255M in Q1, $306M in Q2, $397M in Q3, and $507M in Q4. I’ll be watching whether Q1 2026 holds that $507M base or kicks higher. A flat or sequentially down number would be the first hard data that Anthropic and frontier model labs are siphoning enterprise budgets.

You should also focus on incremental margins. Q4 GAAP operating margin landed at 41%, and the adjusted operating margin hit 57% with net dollar retention of 139%. If U.S. commercial keeps printing triple-digit growth and margins expand again, the commoditization thesis gets reinforced.

Three other inputs matter. First, new TCV bookings after a record $1.3 billion U.S. commercial TCV in Q4. Second, customer count, which grew 49% YoY to 571 U.S. commercial customers. Third, any direct management commentary on Claude or competing model providers. Recent wins like the three-year Cleveland-Cliffs AI partnership announced April 29 give Karp ammunition to argue AIP is widening its lane.

A Test of the Commoditization Thesis

Polymarket traders are pricing in a 95.5% probability of a beat, yet the stock trades at 228 times earnings with 72 recent insider transactions skewed to selling. A clean beat with a raised FY 2026 guide would silence the SaaS-pocalypse worry. Anything softer on commercial revenue or margins puts the Anthropic narrative squarely back on the table.

Photo of Rich Duprey
About the Author Rich Duprey →

After two decades of patrolling the dark corners of suburbia as a police officer, Rich Duprey hung up his badge and gun to begin writing full time about stocks and investing. For the past 20 years he’s been cruising the markets looking for companies to lock up as long-term holdings in a portfolio while writing extensively on the broad sectors of consumer goods, technology, and industrials. Because his experience isn’t from the typical financial analyst track, Rich is able to break down complex topics into understandable and useful action points for the average investor. His writings have appeared on The Motley Fool, InvestorPlace, Yahoo! Finance, and Money Morning. He has been featured in both U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, and USA Today.

Continue Reading

Top Gaining Stocks

MU Vol: 26,371,095
COIN Vol: 5,446,913
EBAY Vol: 11,299,499
ORCL Vol: 19,460,093
MRNA Vol: 2,254,189

Top Losing Stocks

UPS Vol: 8,531,359
FDX Vol: 2,278,612
CHRW Vol: 1,615,740
NCLH Vol: 29,032,643